Translocator Protein 18 kDa (TSPO) Deficiency Inhibits Microglial Activation and Impairs Mitochondrial Function

Rumeng Yao1,2, Ruiyuan Pan3, Chao Shang4

  • 1Department of Neuropharmacology and Drug Discovery, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.

Insights

Translocator protein (TSPO) is crucial for microglial activation and central nervous system (CNS) neuroinflammation. TSPO deficiency impairs microglial metabolism, offering a potential therapeutic target for CNS diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Translocator protein (TSPO) is upregulated in activated microglia within the central nervous system (CNS).
  • The precise role and regulatory mechanisms of TSPO in microglial activation remain incompletely understood.

Purpose of the Study:

  • To elucidate the function and mechanism of TSPO in microglial activation.
  • To investigate the impact of TSPO deficiency on microglial metabolic function.

Main Methods:

  • Primary microglia were isolated from TSPO knockout mice.
  • A TSPO-knockdown microglial cell line was established.
  • Microglial activation was induced using lipopolysaccharide (LPS) or IL-4.
  • Mitochondrial membrane potential, ATP production, and cellular energy metabolism (OXPHOS and glycolysis) were analyzed.

Main Results:

  • TSPO deficiency significantly attenuated LPS- or IL-4-induced microglial activation.
  • TSPO deficiency led to reduced mitochondrial membrane potential and ATP production.
  • TSPO deficiency suppressed mitochondrial oxidative phosphorylation (OXPHOS) and glycolysis, causing metabolic deficits in microglia.

Conclusions:

  • TSPO plays a critical role in microglial activation by regulating mitochondrial metabolism.
  • Targeting TSPO may offer a therapeutic strategy for neuroinflammation-related CNS diseases.